Weekly Trademark Review Feb. 28, 2012
This article was originally published in The Tan Sheet
You may also be interested in...
With makeup and lipstick sales down globally at a time of wide mask use, Shiseido is focused on skin health, planning launches to address sensitive skin needs and heightened demand for cleansing and protection effects. In August, the firm projected a 16% decline in net sales for full-year fiscal 2020.
The European Medicine Agency has recommended extending the therapeutic indication of a raft of drugs that are already authorized in the EU.
Having acquired Jecure Therapeutics and its preclinical portfolio of NLRP3 inhibitors just under two years ago, the Swiss giant has swooped in to buy Dublin-based Inflazome and expand its presence in a hot field of inflammatory research.